PRCT Q3 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$58M+66.3% YoY

Gross Profit

$37M63.2% margin

Operating Income

-$22M-38.4% margin

Net Income

-$21M-35.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$374M

Total Liabilities

$133M

Stockholders' Equity

$241M

Cash & Equivalents

$197M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$35M	+66.3%
Gross Profit	$37M	$19M	+95.6%
Operating Income	-$22M	-$26M	+12.4%
Net Income	-$21M	-$25M	+14.8%

Geographic Segments

UNITED STATES

$52M89%

Outside the United States

$6M11%